Is Sierra Oncology Inc (SRRA) Stock at the Top of the Biotechnology Industry?

Friday, June 17, 2022 12:05 PM | InvestorsObserver Analysts

Mentioned in this article

Is Sierra Oncology Inc (SRRA) Stock at the Top of the Biotechnology Industry?

The 67 rating InvestorsObserver gives to Sierra Oncology Inc (SRRA) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 90 percent of stocks in the Biotechnology industry, SRRA’s 67 overall rating means the stock scores better than 67 percent of all stocks.

SRRA has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on SRRA!

See Full SRRA Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Sierra Oncology Inc Stock Today?

Sierra Oncology Inc (SRRA) stock has gained 0.01% while the S&P 500 is lower by -0.26% as of 12:03 PM on Friday, Jun 17. SRRA is higher by $0.01 from the previous closing price of $54.92 on volume of 67,896 shares. Over the past year the S&P 500 is down -13.37% while SRRA is higher by 199.51%. SRRA lost -$6.76 per share the over the last 12 months. Click Here to get the full Stock Report for Sierra Oncology Inc stock.